Seattle Convention Center | Arch at 705 Pike, Seattle, WA
Managing High Risk Patients
From Risk Calculators to Genetics and High-Risk Benign Lesions
Wednesday, April 29
8:00 AM–12:00 PM
8:00 AM–12:00 PM
Course Moderators: Faina Nakhlis, MD, FACS; Jennifer K. Plichta, MD, MS, FACS
Faculty: Amanda L. Amin, MD, MS, FACS; Judy C. Boughey, MD, FACS; Kevin S. Hughes, MD, FACS; Tari King, MD, FACS; Eric R. Manahan, MD, MBA, FACS; Faina Nakhlis, MD, FACS; Jennifer K. Plichta, MD, MS, FACS; Ashley R. Stuckey, MD, FACOG, FACS
Course Description:
This course is designed to provide you with the resources and knowledge necessary to recognize patients eligible for genetic testing and to perform pre- and post-test. Additionally, this course will provide short-term and long-term management strategies for high-risk breast lesions. Participants will review current screening and surveillance recommendations, as well as breast cancer risk-reducing approaches for high-risk patients with and without germline genetic mutations.
Course Objectives:
At the conclusion of this course, participants should be able to:
- Recognize high-, moderate-, and low-penetrance germline mutations associated with an increased lifetime breast cancer risk.
- Be familiar with breast cancer screening and risk-reduction options appropriate in the setting of a hereditary predisposition to breast cancer.
- Understand proliferative lesions associated with an increased lifetime breast cancer risk.
- Know how to counsel patients with high-risk proliferative lesions found on core needle biopsy and for future breast cancer screening and risk management.
CME Credit Information:
This live activity has been approved for AMA PRA Category 1 Credit™. Check back for credit designation updates.
Onsite Agenda:
| 7:00 AM | Breakfast
|
| 8:00 AM | Welcome and Introduction
Faina Nakhlis, MD, FACS; Jennifer K. Plichta, MD, MS, FACS |
| 8:05 AM | Genetic Testing: Identifying Patients for Testing
Eric R. Manahan, MD, MBA, FACS |
| 8:25 AM | Genetic Testing: How I Do It
Kevin S. Hughes, MD, FACS |
| 8:45 AM | Managing Patients With Germline Genetic Mutations
Ashley R. Stuckey, MD, FACOG, FACS |
| 9:05 AM | Risk Calculators: When to Use Them and When Not to
Judy C. Boughey, MD, FACS |
| 9:25 AM | Q&A
Judy C. Boughey, MD, FACS; Kevin S. Hughes, MD, FACS; Eric R. Manahan, MD, MBA, FACS; Ashley R. Stuckey, MD, FACOG, FACS |
| 9:45 AM | Break
|
| 10:00 AM | Short-term Considerations for High-risk Breast Lesions: ADH, ALH, LCIS
Tari King, MD, FACS |
| 10:20 AM | Long-term Considerations for High-risk Breast Lesions: ADH, ALH, LCIS
Amanda L. Amin, MD, MS, FACS |
| 10:40 AM | Hormone Manipulation in the Setting of Increased Breast Cancer Risk
Ashley R. Stuckey, MD, FACOG, FACS |
| 11:00 AM | Q&A
Amanda L. Amin, MD, MS, FACS; Tari King, MD, FACS; Ashley R. Stuckey, MD, FACOG, FACS |
| 11:20 AM | Ask the Experts: Roundtable Discussion
|
| 11:55 AM | Closing Remarks
Faina Nakhlis, MD, FACS; Jennifer K. Plichta, MD, MS, FACS |
| 12:00 PM | Lunch
|
